Stratifying SSc patients according to antibody positivity (anti-topoisomerase I and anti-RNA polymerase III vs. anti-centromere and ANA), we did not find any statistically significant differences in antibody response nor in the distribution of B-cell subpopulation both at t1 and t3. The gene discussed is BTG3; the disease is systemic sclerosis.